Anatomic repair for congenitally corrected transposition of the great arteries: A single-institution 19-year experience  by Murtuza, Bari et al.
Congenital Heart Disease Murtuza et al
C
H
DAnatomic repair for congenitally corrected transposition of the great
arteries: A single-institution 19-year experienceBari Murtuza, MD, PhD,a David J. Barron, FRCS,a Oliver Stumper, MD, PhD,b John Stickley, BSc,a
Donna Eaton, FRCS,a Timothy J. Jones, FRCS,a and William J. Brawn, FRCSaFrom th
mingh
Disclosu
Read at
gery,
Receive
public
Address
house
nhs.u
0022-52
Copyrig
doi:10.1
1348Objective(s): Anatomic repair for congenitally corrected transposition of the great arteries (ccTGA) has been
shown to improve patient survival. We sought to examine long-term outcomes in patients after anatomic repair
with focus on results in high-risk patients, the fate of the neo-aortic valve, and occurrence of morphologically
left ventricular dysfunction.
Methods: We conducted a retrospective, single-institution study of patients undergoing anatomic repair for
ccTGA. A total of 113 patients from 1991 to March 2011 were included. Double-switch (DS) repair was
performed in 68 patients, with Rastelli-Senning (RS)–type repair in 45. Pulmonary artery banding for retraining
was performed in 23 cases. Patients were followed up for survival status, morbidity, and reinterventions. A
subgroup of 17 high-risk patients in severe heart failure, ventilated, and on inotropes before repair, were included.
Results: Median age at repair was 3.2 years (range, 25 days to 40 years) and weight was 14.3 kg (3.2-61.4).
There were 5 (of 68; 7.4%) early deaths in the DS group and 0 (of 45) in the RS group. Actuarial survivals
in the DS group were 87.6%, 83.9%, 83.9% at 1, 5, and 10 years versus 91.6%, 91.6%, 77.3% in the RS group
(log–rank: P ¼ .98). Freedom from death, transplantation, or heart failure was significantly better in the RS
group at 10 years (P ¼ .03). There was no difference in reintervention at 10 years (DS, 50.3%; RS, 49.1%;
P ¼ .44). In the DS group, the Lecompte maneuver was associated with late reinterventions on the pulmonary
arteries. Overall survival in the high-risk group was 70.6%. During follow-up, 14.2% patients had poor function
of the morphologically left ventricle, all in the DS group, but this was not related to preoperative status or pre-
vious banding. The majority of patients after DS had mild aortic incompetence, which appeared well tolerated.
Annuloplasty of the aortic root at time of DS reduced the risk of late aortic valve replacement.
Conclusions: There is significant morbidity after anatomic repair of ccTGA, which is higher in the DS than the
RS group. Nevertheless, the majority of patients are free of heart failure at 10 years, including high-risk patients
in severe heart failure before repair. Aortic annuloplasty may reduce risk of late aortic insufficiency. (J Thorac
Cardiovasc Surg 2011;142:1348-57)Supplemental material is available online.
The spectrum of presentation of congenitally corrected
transposition of the great arteries (ccTGA) is represented
by a heterogeneous group of patients, both anatomically
and in terms of clinical symptoms and urgency.1 Patients
may have heart failure or cyanosis in infancy or have bal-
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The Journal of Thoracic and Cardiovascular Surdetermined when pulmonary blood flow becomes limiting
or associated lesions become manifest. Physiologic-type re-
pairs addressing isolated associated lesions such as pulmo-
nary atresia or ventricular septal defects (VSDs) have
achieved acceptable results, although often not in patients
with significant tricuspid regurgitation (TR) at the time of
repair.2 Even with no associated lesions, the natural history
of the condition is poor, with only 50% survival at 40 years.
As such, the lesion itself is far from ‘‘corrected.’’ True cor-
rection, in terms of restoring atrioventricular and ventricu-
loarterial concordance, has been achieved by anatomic
repair. Procedures in this class include atrial–arterial switch
(double switch; DS) and the Rastelli-Senning (RS) proce-
dure and its modifications. Late outcomes for these complex
procedures are still poorly understood. We present a large,
single-institution experience of patients with ccTGA under-
going anatomic repair with particular focus on survival,
need for reinterventions, postrepair function of the systemic
morphologically left ventricle (mLV), and outcomes in the
number of high-risk patients with severe congestive cardiac
failure and TR.gery c December 2011
Abbreviations and Acronyms
AI ¼ aortic incompetence
AVR ¼ aortic valve replacement
ccTGA ¼ congenitally corrected transposition of
the great arteries
DS ¼ double switch
ICU ¼ intensive care unit
mLV ¼ morphologically left ventricle
MR ¼ mitral regurgitation
mRV ¼ morphologically right ventricle
PAB ¼ pulmonary artery banding
PAB-P ¼ pulmonary artery banding—protection
PAB-T ¼ pulmonary artery banding—training
PPM ¼ permanent pacemaker
RS ¼ Rastelli-Senning
TR ¼ tricuspid regurgitation
TV ¼ tricuspid valve
VSD ¼ ventricular septal defect
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Follow-up
We conducted a retrospective, single-institution study of all 113 patients
undergoing anatomic repair for ccTGA. Patients from November 1991 to
March 2011 were included. In the same period, there were 26 patients
who were followed up medically or who had undergone physiologic-type
repairs or pulmonary artery banding (PAB) only. Sixty-three patients had
undergone PAB placement at either our own or other institutions before de-
finitive repair: these were for purposes of protection (PAB-P) in patients
with large, unrestrictive VSDs, or to train the mLV (PAB-T) before DS re-
pair where the mLV had not been conditioned by volume or pressure load.
All preoperative and postoperative echocardiographic data were reviewed
to assess morphologically right ventricular/left ventricular (mRV/mLV)
function, atrioventricular and semilunar valve function, ventricular func-
tion, and presence of other associated lesions. One independent cardiolo-
gist (O.S.) determined these parameters to eliminate interobserver bias.
The study was a retrospective review that had been registered with the Bir-
mingham Children’s Hospital Research and Development Board and ethi-
cal approval had been waived by the Central Office for Research Ethics
Committees owing to use of retrospective, anonymized data.
Follow-up postanatomic repair involved electronic patient records
(Heartsuite Database; Systeria Inc, Glasgow, United Kingdom) and corre-
spondence or structured telephone interviews with local referring cardiac
surgeons or cardiologists for patients living abroad. Follow-up involved
assessment of patient New York Heart Association functional status, car-
diac rhythm, and echocardiographic findings. This included focus on the
atrial pathways and the conduit performance, atrioventricular valve or
semilunar valve regurgitation, and ventricular function. All patients in
the study had follow-up to within 1 year of the conclusion of the study
(March 2011). As such, all patients had been followed up from the time
of surgical repair to the end of the study, with none being lost to
follow-up (100% complete).
Surgical Technique
Patients for DS repair underwent Senning arterial switch procedures.
These were divided into patients with small (ie, restrictive) or no VSDs
and those with large (unrestrictive) VSDs. The Lecompte maneuver was
generally performed if the vessels were in an anteroposterior relationship,The Journal of Thoracic and Carbut not if the vessels were side-by-side. In cases of PAB-T, banding was
performed to achieve an mLV/mRV pressure ratio of 0.66:0.75, as previ-
ously described.3 Patients undergoing the RS procedure were usually pal-
liated with a systemic–pulmonary artery shunt before definitive repair and
6 underwent a bidirectional Glenn procedure. Techniques have been de-
scribed in detail previously.4 Three patients in the RS group with a dou-
ble-outlet right ventricle–type arrangement underwent Senning with
intraventricular tunneling of the mLV to the aorta.
In the more recent cases, neo-aortic root annuloplasty was performed if
the predicted size of the root was 2mm ormore greater than predicted using
a 2-layer absorbable purse-string suture placed externally around the root
before implantation of the coronary buttons, tied down over the predicted
size dilator in the outflow tract.
The Senning procedure was used for the atrial switch, with or without
supplementation to the pulmonary venous atrium using autologous (Shu-
maker modification) or pulmonary homograft patch.5 Three patients with
unusual venous anatomy underwent an ‘‘external’’ Senning procedure, as
described previously.6 The systemic venous atrium was not augmented in
any cases.
Statistical Analysis
All data were analyzed using the statistical software package R version
2.11.1 (R Foundation, Vienna, Austria). Continuous variables are presented
as means with the standard deviation or as medians with the stated range.
Comparative univariable analyses were performed using the Kruskal-
Wallis test. Binomial or ordinal data are expressed as percentages, and
comparative univariable analyses were performed using the 2-sided Fisher
exact test. Kaplan-Meier analysis was used for survival with the log–rank
test used to determine significant differences.RESULTS
Patient Demographics, Anatomy, and Surgical
Strategy
A total of 113 patients underwent anatomic repair for
ccTGA. Of these, 68 patients underwent DS, with 2 of these
as staged procedures. Forty-five patients had undergone RS-
type repairs, which included 3 one-and-a-half repairs and 3
double-outlet right ventricle variants with Senning–tunnel
procedures.
The majority of patients in the cohort of 113 patients
were male (73/113), with median age at repair 3.2 years
(range, 25 days–40 years). Median weight at repair was
14.3 kg (3.2-61.4 kg). Morphologic characteristics and as-
sociated lesions are shown in Table 1. Avariety of concom-
itant procedures were performed at the time of anatomic
repair, including pulmonary venous atrium supplementa-
tion, mitral valve repair, and tricuspid valve (TV) repair.
Anterior relocation of the pulmonary artery confluence (Le-
compte maneuver) was performed in 50 patients in the DS
group. Notably, 13 patients in this group also underwent
neo-aortic root annuloplasty, with only 1 such patient in
the RS group (Table E1). In addition, 15 patients in the
DS group had heart block before repair with permanent
pacemakers (PPMs) in situ, although none in the RS group.
Median conduit size in the RS group was 16 mm (14-22
mm). The surgical strategy algorithm is shown in Figure 1.
Twenty-three patients underwent PAB-T; median age at
banding was 2.46 years (0.11-9.82 years), with mediandiovascular Surgery c Volume 142, Number 6 1349
TABLE 1. Patient demographics, morphologies, associated lesions
Characteristic No. of patients (%)
Demographics
Total no. 113
Double switch (DS) 68
Rastelli-Senning (RS) 45
Male/female 73/40
Median age at repair (y) 3.2 (25d-40 y)
Median weight at repair (kg) 14.3 (3.2-61.4)
Morphology
Usual atrial arrangement 103
Situs inversus 10
Azygos continuation of IVC 4
Left atrial isomerism 2
DORV 7
Levocardia 88
Dextrocardia 23
Mesocardia 2
Associated lesions
VSD 89
Ebsteinoid anomaly of TV 14
Severe TR 6*
Pulmonary hypertension 6*
Coarctation/hypoplasia of aorta 20
Interrupted aortic arch 1
Bicuspid AV/PV 2/3
Quadricuspid PV 1
Double orifice TV 2 (1 with straddling)
IVC, Inferior vena cava; DORV, double-outlet right ventricle; VSD, ventricular septal
defect; TV, tricuspid valve; TR, tricuspid regurgitation; AV, aortic valve; PV, pulmo-
nary valve. *All in DS group.
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required a second banding procedure. Thirteen patients had
an unsuccessful PAB-T or were not anatomically suitableFIGURE 1. Surgical strategy algorithm. PA/VSD, Pulmonary atresia/ventricul
pulmonary artery; CP, cavopulmonary.
1350 The Journal of Thoracic and Cardiovascular Surfor repair. ‘‘Failed’’ PABwas defined as not meeting the fol-
lowing criteria: good mLV systolic function; adequate mLV
free wall thickness; adequate mLV pressure generation of at
least 0.66 to 0.75 of mRV (systemic) pressure before repair.
We3 have described these criteria in a previous report.
Of note, 17 patients were classified as high-risk before
anatomic repair, defined as requiring intensive care unit
(ICU) admission, ventilation, and inotropic support preop-
eratively. All had signs of severe congestive cardiac failure,
6 had pulmonary hypertension, and 6 had severe TR. An ad-
ditional 4 patients had severe TR in the group requiring
PAB-T.Intraoperative Data, Survival, and Secondary
Outcomes
Median cardiopulmonary bypass and crossclamp times
were similar in DS and RS groups (Table 2). Median deep
hypothermic circulatory arrest time in the DS group was
15 minutes (0-66 minutes) and 38 minutes (1-74 minutes)
in the RS group. There were 5 (of 68; 7.4%) early deaths
(within 30 days) in the DS group and 0 (of 45; 0%) in the
RS group. There were 5 and 7 late deaths in the 2 groups,
respectively (Table 2). One-, 5-, and 10-year Kaplan-
Meier survivals in the DS group were 87.6%, 83.9%, and
83.9%. Respective survivals for the RS group were
91.6%, 91.6%, and 77.3%. There was no significant differ-
ence between groups (Figure 2, A; log–rank, P ¼ .98).
There were 3 unexpected deaths in our series. None of
these patients were in the high-risk group before repair.
Two had undergone RS at 13 months and 5 years of age
and died after initial good progress at 10 and 14 years of
age, respectively. The third patient underwent DS at 2 yearsar septal defect; PS/VSD, pulmonary stenosis/ventricular septal defect; PA,
gery c December 2011
TABLE 2. Outcomes for patients undergoing anatomic repair
Outcome DS RS
Mortality
No. of patients (n) 68 45
Early deaths (n) 5 (7.4%) 0 (0%)
Late deaths (n) 5 (7.4%) 7 (15.5%)
High-risk group 17
Early deaths 3 (17.5%) 0
Late deaths 2 (11.7%) 0
Perfusion and ischemic times*
CPB time (min) 176 (102-492) 132 (66-218)
Crossclamp time (min) 134 (69-258) 114 (44-169)
Circulatory arrest time (min) 15 (0-66) 38 (1-74)
Secondary outcome measures
Median ICU length of stay (d) 3.2 (0.1-47.8) 5.2 (1.8-48.9)
Median hospital LOS (d) 14.0 (0-86.0) 20.5 (0-84.0)
ECMO 4 (1 late) 0
Transplanted 3 0
Neurologic event 1 3
Tachyarrhythmias after repair 3 1
PPM insertion
Operative 10 5
Preoperative 15 0
DS,Double switch; RS, Rastelli-Senning; CPB, cardiopulmonary bypass; ICU, inten-
sive care unit; LOS, length of stay; ECMO, extracorporeal membrane oxygenation;
PPM, permanent pacemaker. *Times stated as median with range.
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peated episodes of ventricular fibrillation just before ICU
transfer and, despite reinstitution of cardiopulmonary by-
pass, the heart persisted in ventricular fibrillation. No struc-
tural reason for this outcome could be found. The single
patient who died after DS procedure owing to persistent
ventricular fibrillation had received a PAB for protection
for unrestrictive VSD and not for training the mLV. There
were no further data available concerning the mechanism
of death for the 2 patients who died late unexpected deaths
in the RS groups, 1 of whom was followed up abroad.
In terms of secondary outcome measures, 3 patients from
the DS group underwent late transplantation and 4 patients
in this group required postoperative extracorporeal mem-
brane oxygenation: 2 for postoperative cardiac support, of
whom both survivedwith good function, and 1 late readmis-
sion requiring aortic valve replacement (AVR) who sur-
vived but has poor mLV function; the final case was for
respiratory support, having developed respiratory syncytial
virus–positive bronchiolits late postoperatively (this patient
was a late death). There were 4 patients who had significant
neurologic injury after surgery: 1 in the DS group and 3 in
the RS group (2 of whom were late deaths). The median
ICU and hospital lengths of stay were similar (Table 2).
Postoperative PPM insertion for heart block was required
in 10 DS patients and 6 RS patients. Three of these patients
went on to have an upgrade to biventricular pacing systems
to achieve better resynchronization, 1 with dramaticThe Journal of Thoracic and Carimprovement in mLV function. There was a low incidence
of tachyarrhythmias overall. Preoperatively, 3 DS patients
and 1 RS patient had supraventricular tachycardia; 1 of the
3 DS patients had Wolf-Parkinson-White syndrome. After
repair, tachyarrhythmia developed in 4 patients: 3 DS and
1RS (Table 2). All 3 of theDS patients required electrophys-
iologic studies and catheter ablations (1 for ventricular
tachycardia; 2 for supraventricular tachycardia). Overall,
54 of the 58 patients in the DS group and all surviving 38
RS patients are in New York Heart Association class I/II.
Reinterventions After Anatomic Repair
Overall, there were 41 reinterventions in 13 DS patients
and 34 interventions in 16 RS patients during follow-up.
These reinterventions included both surgical and catheter
procedures, although excluding insertion of PPMs and the
single patient who was readmitted and required extracorpo-
real membrane oxygenator support. The most frequent
intervention in the RS group was for right ventricular–
pulmonary arterial conduit ballooning or exchange (14 pa-
tients; Table 3). Of note, 6 AVRs were required in the DS
group for progressive aortic incompetence (AI), although
only 1 in the RS patients. Reinterventions on the Senning
pathways were required in 12 patients; 5 were operative
(4 pulmonary venous obstruction and 1 superior vena
cava pathway) and 7 were catheter interventions (all supe-
rior vena cava pathways). Four patients in the RS group re-
quired relief of mLVoutflow tract obstruction, although in 2
cases the obstruction was not severe and was relieved as
a concomitant procedure at the time of necessary conduit re-
placement. When censoring deaths and right ventricular–
pulmonary arterial conduit interventions/changes in the
RS group, the Kaplan-Meier freedom from reintervention
at 10 years in both groups was very similar: DS, 50.3%;
RS, 49.1% (Figure 2, B; log–rank, P ¼ .44).
During follow-up, the incidence of mild to moderate AI
in the DS group was 40 (of 58; 70%) compared with 8
(of 38; 21%) in the RS group, all of which were mild. An
additional 6 patients in the DS cohort had severe AI during
follow-up and underwent AVR, compared with 1 AVR for
severe AI in the RS cohort. Aortic root annuloplasty was
performed in 13 patients owing to the finding of a dilated
annulus and/or prolapsing aortic leaflets at time of DS.
Follow-up of these patients showed less AI in this cohort
than in the whole DS group, but the difference did not reach
statistical significance (Figure E1). None of these patients
has required AVR.
Mild tomoderate mitral regurgitation (MR) occurred dur-
ing follow-up in 31% of the DS group and 14.3% in RS
group. Mild to moderate TR occurred in 27.6% in the DS
group compared with 40% in the RS group. No patients
in either group had severe MR or TR. The stated incidence
of MR represents a new incidence of MR after anatomic
repair, although the precise timing of this valvulardiovascular Surgery c Volume 142, Number 6 1351
FIGURE 2. A, Survival (death) after ccTGA repair. B, Freedom from reintervention after ccTGA repair. C, Freedom from death, transplantation, or poor
mLV function. ccTGA, Congenitally corrected transposition of the great arteries; mLV, morphologically left ventricle.
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concerning the preoperative incidence of MR were not
available and thus we have been unable to relate this to
the postoperative incidence of MR. In fact, the occurrence
of new MR after repair was only mild in the majority of
cases (total incidence of new MR in DS group, 31%-
22.4% mild; total incidence of new MR in RS group,
14.3%-11.4% mild). There was no significant difference
in incidence of postoperative MR in those with/without pul-
monary venous atrium supplementation, and as such it
would be difficult to attribute the development of new MR
to the Senning technique. Finally, only qualitative data on
mLV function late after repair were available, although it
would be interesting to obtain more quantitative data on
mLV cavity size and geometry late postoperatively to ascer-
tain whether these were related to the incidence of late MR.
The Lecompte maneuver was performed in 50 of
the 68 DS group, and 5 of these patients required 81352 The Journal of Thoracic and Cardiovascular Surreinterventions on the pulmonary arteries. This compares
with zero reinterventions in the 18 patients in whom the
pulmonary arteries were left in the native position (log–
rank, P ¼ .2; Figure E2).
Outcomes in High-Risk DS Patients and Those With
Poor mLVAfter Repair
There were 17 high-risk patients, all in the DS group.
These patients had severe heart failure and required
ICU admission, ventilation, and inotropic support preop-
eratively; 6 of 17 patients had severe TR and 6 of 17 pul-
monary hypertension. All these patients fell into the DS
group and 11 of 17 were first banded with or without
arch repair (Figure 1). The remaining 6 patients had DS
procedures without prior banding. There were 3 early
and 2 late deaths in the high-risk group (70.6% survival).
Two of these early deaths were in patients who had been
banded.gery c December 2011
TABLE 3. Reinterventions for DS and RS patients
Reintervention DS RS
AVR 7* 1
MV repair 1 0
TV repair 3 0
RF ablation for atrial flutter 4 0
Multisite resynchronization 3 0
Aortic angioplasty 0 1
Residual VSD 3 0
LVOTO resection 0 4
SV pathway 3 (3 balloon) 5 (4 balloon;
1 stent)
PV pathway 4 0
Senning takedown 0 1
PA confluence reconstruction 8 3 (2 balloon)
RPA intervention 3 (1 balloon;
2 stents)
2
LPA intervention 0 3 (balloon)
RVOT enlargement 2 0
Balloon to RV-PA conduit n/a 2 (balloon)
RV-PA conduit change n/a 12
Total No. of reinterventions 41 34
DS, Double switch; RS, Rastelli-Senning; AVR, aortic valve replacement; MV, mitral
valve; TV, tricuspid valve; RF, radiofrequency; VSD, ventricular septal defect;
LVOTO, left ventricular outflow tract obstruction; SV, systemic venous; PV, pulmo-
nary venous;PA, pulmonary artery; RPA, right pulmonary artery; LPA, left pulmonary
artery; RVOT, right ventricular outflow tract; RV-PA, right ventricular–pulmonary
arterial; n/a, not applicable. Catheter interventions are in parentheses. *Includes 1 ad-
ditional AVR at the time of initial surgical repair.
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of the DS group (ie, elective or low-risk DS), the early
mortality is 17.5% compared with 3.9% (P ¼ .06). In
terms of ventricular function, 5 of the 17 high-risk pa-
tients had poor mLV function after repair and 4 of these
died (2 early deaths; 2 late deaths). The corollary of this
is that, among the early survivors of the high-risk group,
80% have well preserved mLV function at follow-up
(Table E2).
Taking into account all 113 patients with anatomic re-
pairs, there were 16 (14.2%) patients with poor mLV func-
tion detected during follow-up. All were in the DS cohort
and only 5 of the16 were high-risk patients in heart failure
before repair. Of the 11 remaining patients, 7 had been
banded for mLV training. Taking these 7 patients with
PAB-Twho developed poor mLV function after repair, me-
dian age at banding was 3.03 years (0.29-9.82 years), with
a median duration of banding of 579 days (5-939 days), and
3 of these 7 patients had required 2 PAB-T procedures. In
comparison, for the 15 other patients with PAB-T who did
not have poor mLV function postoperatively, median age
at banding was 2.1 years (0.11-7.97 years; P ¼ not signifi-
cant). Median duration of banding was 544 days (25-2758
days; P ¼ not significant), but none required more than 1
banding procedure. Whereas neither the age at banding
nor duration of banding exhibited a statistically significantThe Journal of Thoracic and Cardifference between groups who did/did not develop late
mLV dysfunction, the numbers of patients were relatively
small. Further, analysis of Kaplan-Meier survival at 1, 5,
and 10 years did not demonstrate any significant difference
among DS patients who had undergone PAB-T compared
with those who had not (log–rank, P ¼ .31).
Despite a high incidence of mild to moderate AI in the
DS group, there was no association between this and late
mLV dysfunction (Table E2). Similarly, only 4 of these
16 patients had mild to moderate MR. When taken to-
gether as a combined end point, freedom from death,
transplantation, or poor mLV function was significantly
worse for the DS group at 1, 5, and 10 years when com-
pared with the RS group (log–rank, P ¼ .03; Figure 2,
C). This is in contrast to the raw survival as shown in
Figure 2, A.
DISCUSSION
This study has demonstrated that in a large cohort of pa-
tients with ccTGA, there is a heterogenous mix of anatomic
and functional subtypes as well as a wide variability in pre-
operative clinical status. Despite overall encouraging early
mortality for anatomic repair, we have highlighted that
there is a significant late morbidity in these patients, partic-
ularly in the DS group.
Other than the requirement for conduit replacement, the
ccTGA patient with large VSD and pulmonary stenosis/pul-
monary atresia (ie, the RS group) have excellent early and
late outcomes and appear to be much more likely to remain
free of late ventricular dysfunction or AI. We observed
a low incidence (4 patients) of late subaortic obstruction
in the RS group. The Senning component of the procedure
is not without late morbidity, particularly pathway obstruc-
tion, although the majority of cases can be successfully
treated with catheter intervention. Four of 113 patients sus-
tained significant neurologic injury. The observed neuro-
logic injuries did not occur in the setting of multiple
cardiac arrests, although they were, we believe, partly at-
tributable to low cardiac output after repair. Cranial imaging
in these patients did not suggest that there had been embolic
events, nor was there any suggestion that these events had
been related to complexities of intraoperative cannulation
or perfusion.
The incidence of tachyarrhythmias in our series was en-
couragingly low, given the concerns that have been raised
with long-term follow-up of the atrial switch procedures.2,7
Freedom from reintervention was the same for both the DS
and RS groups at 5 and 10 years, and overall reintervention
rates are similar to other reported series.2,8,9 Despite the
requirement for conduit replacement in the RS group, the
overall reintervention rates are similar for both groups,
predominantly owing to the increased need for aortic
valvular and pulmonary artery reinterventions in the DS
group.diovascular Surgery c Volume 142, Number 6 1353
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In this series, 12.4% of patients had an ebsteinoid anom-
aly of the TV. TV repair was performed at the time of repair
in 13.2% of DS patients, and in over half the cases this in-
volved closure of a cleft in the septal leaflet. Our intraoper-
ative strategy was to briefly examine the TV in all cases.
Only patients in whom there was an evident gap or cleft
in the valve underwent repair at the time of DS or RS pro-
cedure. Postoperative incidence of mild to moderate TR
was 27.6% in the DS group and 40% in the RS group.
The high incidence in the latter may reflect an approach
that could be more aggressive in terms of treating milder
forms of TV dysplasia at the time of initial repair. In
many cases, it was anticipated that restoration of the TV
to the low-pressure pulmonary circulation would result in
improvement in the TR after repair, as has been reported
by other investigators.
Restoring the mRV to the low-pressure pulmonary cir-
culation has been shown to markedly reduce TR just by
virtue of mechanical unloading of the mRV and septal
shift with restoration of the mLV to the systemic circula-
tion.4,10 Although this is clearly important, our results
would suggest that there may still be a role in assessing
the TV carefully with a low threshold for repair a time
of surgery.
Senning pathway reintervention rate was 11%, which
was higher than we had seen in shorter follow-up studies.4
Although the majority of patients were successfully treated
by interventional catheterization, pulmonary venous path-
way obstruction required surgical relief in all 4 patients.
Others have reported similar venous pathway reintervention
rates, and although the Senning is the most widely reported
technique, there remains no consensus as to whether the
Mustard or Senning procedure provides better long-term re-
sults in this setting.7,10 Our results did not show that
augmentation of the pulmonary venous baffle at the time
of initial surgery affected reintervention rates.
Neo-Aortic Incompetence After DS
The majority (70%) of patients after DS repair had at
least mild AI at follow-up. Six of the surviving DS patients
had severe AI requiring AVR, with 1 additional patient un-
dergoing AVR at the time of repair. It is clear, however, that
mild AI is well tolerated by the majority of DS patients and
it did not correlate with late mLV dysfunction. There are po-
tentially anatomic and surgical substrates for the develop-
ment of AI in these patients.1,11 The neo-aortic root
dilatation observed in the DS patients occurred primarily
at the level of the ventriculoarterial junction, below the level
of the coronary arteries. The purse-string suture placed was
4-0 PDS (Ethicon, Inc, Somerville, NJ) at this level as a dou-
ble running suture. Clinical observations from our early
experience with the DS procedure suggested that postoper-
ative AI was associated with anatomic repair, and as a result1354 The Journal of Thoracic and Cardiovascular Surwe examined more critically the need for reduction of the
neo-aortic annulus with a 2-layer annuloplasty stitch placed
before reimplantation of the coronary buttons. As such, our
approach to minimize AI represents an evolution in surgical
technique over time, and we now routinely perform an ob-
jective assessment of the neo-aortic valve/root at the time of
repair. In the present series, a repair was performed in 13 pa-
tients in the DS group with encouraging outcomes and min-
imal AI at follow-up. It is possible, however, that a more
aggressive approach to tailoring of the neo-aorta at the
time of anatomic repair might reduce the incidence of AI,
and this is an area for potential improvement in the DS
procedure.
Reinterventions for Right Ventricular–Pulmonary
Arterial Conduits and Pulmonary Arteries
The commonest reinterventions in the RS group were for
conduit changes. This reflects the natural history of these
conduits as well as natural outgrowth.11-13 Malhotra and
associates9 report improved conduit performance using
their strategy of DS with one-and-a-half–type repair with
cavopulmonary shunts, attributing conduit longevity to re-
duced forward flow. This is an attractive strategy but must
be balanced by the potential concerns over the one-and-a-
half–type repair (reduced functional status, problems in
the setting of high pulmonary vascular resistance, and loss
of access for pacing intervention).
In the DS patients, all 8 reinterventions (in 5 patients) on
the pulmonary arteries occurred in patients who had under-
gone the Lecompte maneuver. No reinterventions were nec-
essary in the (smaller) group of patients in whom the
pulmonary arteries had been left in their native position.
The Lecompte maneuver is not always straightforward in
the DS inasmuch as the great vessels are frequently side-
by-side; furthermore, the older age and previous procedures
in these children often make the pulmonary arteries much
less mobile and flexible than in a regular neonatal arterial
switch. The evidence would suggest that the Lecompte ma-
neuver may produce particular problems in the setting of the
DS and that it may be more appropriate to leave the pulmo-
nary arteries posteriorly, even if this requires supplementing
the main pulmonary artery to allow more length. Our cur-
rent practice is to only perform the Lecompte if the vessels
are in an anteroposterior relationship and can be freely
mobilized.
We did not observe any instances in which acute coronary
compression resulted in early mortality. Importantly, how-
ever, in 3 patients after DS procedure, there was difficulty
in weaning from cardiopulmonary bypass that appeared to
be related to the geometry of the pulmonary artery recon-
struction after the Lecompte maneuver. The main pulmo-
nary artery was therefore lengthened with a subsequent
uneventful postoperative course. It would be interesting,
however, to determine whether any degree of chronicgery c December 2011
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and this would be an area for further study.
High-Risk Patients Undergoing DS and Poor mLV
Function After Repair
In this study we focused in particular on outcomes
achieved in high-risk patients with ccTGAwho had severe
heart failure with associated moderate to severe TR and pul-
monary hypertension in some cases. Significant TR and im-
paired mRV function before repair have been widely
documented to be risk factors for mortality after physio-
logic and anatomic repair for ccTGA.2,7,14,15 All of these
high-risk patients fell into the DS group in terms of under-
lying anatomy, and it is important to note that the VSD/pul-
monary stenosis group of patients do not present with
uncontrolled heart failure or severe TR. The poor preoper-
ative status of this group of patients was reflected in the rel-
atively high early mortality (17.5%), but it was encouraging
to note that the long-term outcome for this group was good,
being similar to that of the low-risk DS and with no in-
creased incidence of poor mLV function.
During follow-up, 14.2% of patients had poor mLV func-
tion, all of whom were in the DS group; an incidence of
18% to 20% has been reported by others, and this may
be both systolic and diastolic dysfunction.7,10,16 In terms
of the etiology of this marked impairment of function,
possible factors to consider are the following: PAB-T dura-
tion and age at training; presence of neo-AI; presence of
MR after repair; heart block requiring PPM insertion; and
preoperative heart failure.16
The need to train the mLV before DS has previously been
cited as a risk factor for late outcome.17 However, the use of
PAB-Twas not associated with poor outcome in this analy-
sis. Furthermore, we found that neither age at banding nor
duration influenced development of late mLV dysfunction.
One aspect of our strategy that has evolved over time is
the tendency to apply PAB-T in younger patients inasmuch
as they appear to have a more favorable response, perhaps
related to hyperplasia of cardiac myocytes as opposed to
a hypertrophic response.18
Despite mild AI being common, our results did not sug-
gest that either AI or MR was correlated with deterioration
in mLV function, as only 4 of 16 patients with poor mLV
function had associated moderate to severe AI and only 4
of 16 had associated mild to moderate MR. Further, only
3 of 16 patients required postoperative PPM insertion, al-
though data on electrocardiographic QRS complex dura-
tion, predictive of mLV dysfunction in this context, were
not available.16
It is difficult, therefore, to attribute mLV failure to any
single factor in our patient cohort. The cause is likely to
be multifactorial, although it was notable that late mLV dys-
function occurred exclusively in the DS group. One further
observation is the presence of mild mLV dilatation in theThe Journal of Thoracic and Carmajority of patients, although this is difficult to quantify ob-
jectively. Early, reproducible, standardized assessment of
such subtle changes in mLV size, geometry, and function
might identify patients who would benefit from alteration
of their medical therapy to perhaps modulate any potential
adverse remodeling of the myocardium and improve long-
term clinical outcomes and functional status. In our series,
3 patients received multisite pacing for resynchronization
therapy, and an earlier role for this in the deteriorating
mLV may prove valuable.16 The role of pharmologic mod-
ulation of mLV function, such as with angiotensin-
converting enzyme inhibitors, was not formally evaluated
in this study.CONCLUSIONS
Although the majority of patients remain well after ana-
tomic repair of ccTGA, there is significant late morbidity.
Long-term surveillance of patients is required to identify
any deterioration in systemic mLV, atrioventricular valve,
and neo-aortic valve function, as well as to detect Senning
pathway obstructions. The DS group is at significantly
higher risk for the development of late mLV dysfunction
and AI than the RS group. Careful assessment of the aortic
valve at the time of DS and avoidance of the Lecompte
maneuver in side-by-side vessel arrangements may help to
improve long-term outcomes. Anatomic repair has encour-
aging results for symptomatic patients, in particular those
with significant TR and severe heart failure.
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Dr Richard A. Jonas (Washington, DC). I have no disclosures.
Dr Barron, many thanks for sending me the manuscript. This is
obviously a complex area and you have a huge amount of data, so it
was very helpful to be able to look at the manuscript ahead of time.
You are certainly to be congratulated on this additional, ex-
tremely important contribution regarding the challenging problem
of ccTGA. It was just over 20 years ago that Dr Michel Ilbawi in-
troduced the concept of the double switch (DS) procedure and held
out hope for this difficult problem of ccTGA. Until that time the
results of traditional surgery, which left the right ventricle as the
systemic ventricle, resulted in dismal long-term outcomes, as
was so ably documented by Dr Viktor Hraska when he was with
our group in Boston. Although encouraging early results were re-
ported for the DS by Professor Imai’s group at Tokyo Women’s
Medical College and Dr Roger Mee in Melbourne, as well as Dr
Brawn and your group in Birmingham, this most recent analysis1356 The Journal of Thoracic and Cardiovascular Surwill surely lead all of us to rethink which patients are best managed
by this procedure.
I would like to highlight some of the disturbing points that Dr
Barron has just presented to us. First, late left ventricular dysfunc-
tion is not uncommon. Recent reports had already raised that sus-
picion, but what is of greater concern is that late left ventricular
dysfunction cannot be accurately predicted. I think we were all
hopeful that training of the left ventricle at an older age, such as
greater than 12 or 15 years, or the presence of preoperative heart
failure or the presence of postoperative valve dysfunction might
have been predictive of late left ventricular dysfunction. Regretta-
bly, none of this has been documented by the analysis we have just
heard. In fact, this large experience raises the question whether the
fundamental premise that the child with ccTGA must always be
better off with a systemic mLV and a biventricular circulation is
correct.
What is of equal concern to the high incidence of late left ven-
tricular dysfunction is the high incidence of late need for reopera-
tion and reintervention. The DS patients not only had a higher
incidence of late left ventricular dysfunction relative to the RS
patients, but in addition they had a surprisingly high rate of late
aortic valve regurgitation and pulmonary artery problems, partic-
ularly after a Lecompte maneuver. These problems were less fre-
quently seen in the RS patients, but surely this latter option is in
other respects a less desirable option than a true DS since it con-
demns patients to a lifetime of conduit changes. Conduit changes
can be a particular problem when the patient has dextrocardia,
which applied to more than 20% of your patients in this series
and in many other series has applied to as many as one third of
all patients. And for both groups reoperations were needed for
the Senning pathways, both systemic and pulmonary, which leads
to my questions:
First, is there ever a place for a prophylactic DS in the child with
an intact septum and no TR?What sort of associated problems like
a mild degree of Ebstein-like malformation of the TVor congenital
heart block might lead you to do a prophylactic DS?
Dr Barron. Thank you very much for your very fair comments.
I completely agree. It has raised concerns in all our minds about the
long-term management of these patients. Absolutely, it is patient
selection—who needs what operation at what time—that is the
key.
I am not sure whether many people would ever have suggested
that doing a prophylactic DS in a child who is completely well, has
no TR, and a good functioning systemic right ventricle, that put-
ting them through this major maze operation, would be the right
thing to do. So no, I do not think there is any place for prophylactic
DS.
Now, if they have a degree of TR, then it starts to get a bit trick-
ier because the natural history is bad. As soon as they have mod-
erate or greater TR, they are on a bad survival curve, and that is
more difficult. The first thing I would say is that I think there is
a place for a PAB in that situation, because that in itself may treat
the TR and buy some time. You are setting them on that track to-
ward DS at that stage. However, that may well be their best out-
come despite what we are saying here.
Dr Jonas.Would it be fair to say that the bar is shifted slightly
against the DS in terms of these patients who do not have a VSD
and who have an intact septum?gery c December 2011
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we are all conscious of the patients in whom symptoms develop.
The more difficult problem is the ones who do not have symptoms
but whose right ventricle does not look good or who have some
TR.
Dr Jonas. Second, how important is dextrocardia as a contrain-
dication to an RS procedure in view of the risk of proximal conduit
compression by the sternum and need for frequent conduit
changes?
Dr Barron. In our series I would not say it has been a major
concern, and we certainly would not regard it as a contraindication
to the DS. Certainly dextrocardia makes the operation technically
more difficult to do, but we can be reassured by the fact that the
operative results for the RS have been very good. I you look at
the incidence, we have only had to actually replace 12 conduits
in thewhole population over the 19 years of this study. So the com-
mitment to lots of operations for conduit replacement does not
seem to be too bad.
We have not analyzed it specifically to look at whether the dex-
trocardia patients are those who have needed more conduit re-
placement, so I could not answer that.
Dr Jonas. Third, I have a question about PAB. To whom do you
now offer left ventricular preparation by PAB? Do you see a role
for PAB as destination therapy to induce septal shift to treat TR
in the patient with an intact septum and low left ventricular
pressure?
Dr Barron. I do not think we would consider PAB unless the
patients had evidence that they were running into trouble, that
they had moderate TR, or that they had some dysfunction or
some signs of dilatation of the mRV. Those are the patients we
would select for banding at that point. I quite agree that the band-
ing itself will cause septal shift and may reduce the TR and symp-
toms in many of the patients.
Whether that will be the destination, I do not think I could an-
swer. I think each patient must be evaluated individually. Once
PAB is done, you are making a commitment that you would be ex-
pecting to take them through a DS. If they remain well with the
PAB on, they should be safe and there is no reason not to just
keep watching them, indefinitely if need be. But in our experience,
with the majority of patients, once TR and right ventricular dilata-
tion have developed, they are going to ultimately get systemic ven-
tricular failure and they will need something.
Dr Jonas. You can certainly make the argument that the left
ventricle is going to manage the banded pressure over the lon-
ger-term. If the TR is stable and the septum remains shifted across,
perhaps in the long-term that would be a more satisfactory out-
come than some of the multiple reinterventions that you have
documented.
Final question: What is the role of the Fontan operation versus
the DS in light of the results that you have presented?The Journal of Thoracic and CarDr Barron. There are certain populations within this group of
patients for whom the Fontan would be a good and a valid alterna-
tive. I do not think there is any role for it in the DS-type population,
because you have not removed the concern of the mRV failing or
the TR becoming a problem. If you take them through a Fontan
program, that risk is still there.
I guess the Fontan is more appropriate in the group of patients
who are in the RS group, in whom you would avoid the whole
problem of having to place a conduit, perhaps the risk of heart
block and the risk of leaving a left ventricle–aortic tunnel. And
you know that the Fontan is a pretty safe operation.
We are all kind of hard-wired to think that if the patients have 2
ventricles, it is a sin to take them through a Fontan circulation, and
that is something we can debate. However, I think the functional
performance and the functional result the patients get with a biven-
tricular repair, which in this case means RS versus the Fontan, is
better with an RS. Thus I would still put my vote for a biventricular
repair with an RS, and I think that is supported by these outcomes.
We know that the Fontan, although safe, has a long-term attrition. I
would argue it might be worse than we are going to see in the RS
group. Certainly there are patients in the RS group who have an
uncommittable VSD, and in those patients I think there is a very
good argument for doing a Fontan rather than a conventional phys-
iologic repair.
Dr Jonas. Thank you. Once again, congratulations, this is going
to be a really important contribution.
Dr Rodolfo A. Neirotti (Cambridge, Mass). Congratulations
for your large number of patients and for being honest in pre-
senting the data in which you have shown some long-term prob-
lems that can be useful for others trying to use the same
approach.
I would like to expand on Richard Jonas’s question, and that
is, the place of the Fontan operation. In patients with ccTGA
and large VSDs, the ventricular dysfunction appears usually after
the septation. In this cohort of patients, after the Fontan opera-
tion, the 2 ventricles function as a large single chamber, with
a single outlet, an anatomy and physiology that may result in
a better ventricular function than when you do the septation
and the DS.
Dr Barron. No, I think that is a fair comment. If you use the
Fontan approach, they will fall into the better series of Fontan out-
comes. However, I still believe that a biventricular repair provides
a better functional result. The results here would support the fact
that so long as they have a suitable anatomy where the Rastelli
is readily performed, the left ventricle can be committed back to
the aorta without causing any obstruction within the ventricle. I
think the functional outcome for those patients would still be supe-
rior than to do a Fontan.
Dr V. S. Reddy. David, I think you can discuss it later because
we are way over time.diovascular Surgery c Volume 142, Number 6 1357
FIGURE E1. Follow-up after aortic root annuloplasty.
FIGURE E2. Follow-up after the Lecompte maneuver.
TABLE E1. Concomitant surgical procedures at time of anatomic repair
Group
Concomitant procedure
Aortoplasty/neo-AV repair MV repair TV repair PV atrium supplementation Lecompte maneuver
DS (n ¼ 68) 13 3 9 19 50
RS (n ¼ 45) 1 0 0 17 0
Figures are numbers of patients. AV, Aortic valve; MV, mitral valve; TV, tricuspid valve; PV, pulmonary venous; DS, Double switch; RS, Rastelli-Senning.
TABLE E2. Development of poor mLV function during follow-up
Moderate/good mLV Poor mLV
Double switch 42/63 (75%) 16/63 (25%)
Rastelli-Senning 45/45 (100%) 0/45 (0%)
High-risk group 12/15 (80%) 3/15 (20%)
Moderate AI or AVR 7/92 (6%) 3/16 (19%)
Previous PAB 53/92 (58%) 7/16 (44%)
Duration PAB 554 d 579 d
Early deaths were excluded. mLV, Morphologically left ventricle; AI, aortic insuffi-
ciency; AVR, aortic valve replacement; PAB, pulmonary artery band.
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